Endoscopic combination therapy with photodynamic therapy and endoscopic resection for wide circumferential local recurrence after radiotherapy for esophageal cancer
- PMID: 40843084
- PMCID: PMC12366453
- DOI: 10.1016/j.vgie.2025.04.007
Endoscopic combination therapy with photodynamic therapy and endoscopic resection for wide circumferential local recurrence after radiotherapy for esophageal cancer
Abstract
Background and aims: For wide-circumferential local recurrence after chemoradiotherapy or radiotherapy (RT) for esophageal squamous cell carcinoma (ESCC), salvage surgery is performed, but combination therapy with photodynamic therapy (PDT) and endoscopic resection (ER) could be an alternative treatment for a T1b-T2 lesion. The aim of this report is to present the case of a patient in whom we achieved local control with combination therapy.
Methods: The patient was an 86-year-old man who underwent RT for cT2N1M0 ESCC. After RT, a local residual lesion was found of 30 mm, three-fourths of the circumference, and type 0-Is+IIc. Laser illumination was first performed to focus on the 0-Is portion, suspected submucosal invasion, and, thereafter, treatments such as ER or additional PDT were planned for nontreated 0-IIc areas, depending on the response of 0-Is after PDT.
Results: After initial PDT, 0-Is markedly shrunk, and a significant response was achieved; therefore, ER was performed on 0-IIc lesions. Subsequently, local recurrence occurred in the laser-illuminated 0-Is; therefore, 2 additional PDT sessions were performed. After the last PDT, local control was achieved and the patient has survived without recurrence for more than 3 years. No severe adverse events occurred.
Conclusions: Combination therapy with PDT and ER may be a less-invasive and potentially curative treatment option for patients with wide-circumferential local recurrence.
© 2025 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc.
Conflict of interest statement
T. Yano has received research grant support from Olympus, Fujifilm, and HOYA; is a consultant for Olympus and Fujifilm; and is a speaker for Olympus, Fujifilm, and Meiji Seika Pharma. T. Kadota is a speaker and an advisor for Olympus. All other authors disclosed no financial relationships.
Figures
References
-
- Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer long-term follow-up of a prospective randomized trial (RTOG 85-01) JAMA. 1999;281:1623–1627. - PubMed
-
- Yano T., Muto M., Hattori S., et al. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy. 2008;40:717–721. - PubMed
-
- Nakajo K., Yoda Y., Hori K., et al. Technical feasibility of endoscopic submucosal dissection for local failure after chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma. Gastrointest Endosc. 2018;88:637–646. - PubMed
-
- Sugawara K., Mori K., Yagi K., et al. Association of preoperative inflammation-based prognostic score with survival in patients undergoing salvage esophagectomy. Dis Esophagus. 2019;32 - PubMed
LinkOut - more resources
Full Text Sources
